May 2, 2024 8:31 PM
BACK TO TOP
KSE100
70,657.64
-444.90
(-0.63%)
ALLSHR
46,150.31
-403.92
(-0.87%)
KSE30
23,234.08
-160.57
(-0.69%)
KMI30
118,759.78
-685.01
(-0.57%)
BKTI
17,553.50
-85.78
(-0.49%)
OGTI
16,761.29
-23.85
(-0.14%)
KMIALLSHR
33,049.28
-223.10
(-0.67%)
PSXDIV20
28,247.77
-132.80
(-0.47%)
UPP9
21,019.74
-134.42
(-0.64%)
NITPGI
17,016.75
-82.94
(-0.49%)
NBPPGI
19,068.71
-59.41
(-0.31%)
MZNPI
15,700.49
-94.57
(-0.60%)
JSMFI
18,917.68
-157.98
(-0.83%)
ACI
11,482.12
18.51
(0.16%)
JSGBKTI
18,483.86
4.22
(0.02%)
MII30
10,797.85
-71.49
(-0.66%)
HBLTTI
13,823.83
29-04-2024
-0.73
(-0.01%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.25.61
-0.77
(-2.92%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, May 2, 2024 4:14 PM
REG
FUT
ODL
Open
26.30
High
26.60
Low
25.50
Volume
1,072,980
CIRCUIT BREAKER
24.40 — 28.36
DAY RANGE
25.50 — 26.60
52-WEEK RANGE
19.07 — 28.35
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
26.38
VAR
10.50
HAIRCUT
15.00
P/E Ratio (TTM) **
7.28
1-Year Change *
-2.70%
YTD Change *
7.88%
Last update: Thu, May 2, 2024 4:00 PM
Open
26.77
High
27.00
Low
25.85
Close
26.02
Change
-2.80%
LDCP
26.77
Volume
105,000
Total Trades
80
CIRCUIT BREAKER
24.76 — 28.78
DAY RANGE
25.85 — 27.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Tue, Apr 2, 2024 8:00 AM
Open
0.00
High
0.00
Low
0.00
Close
24.58
Change
0.00%
LDCP
27.48
Volume
0
Total Trades
0
CIRCUIT BREAKER
25.42 — 29.54
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Mon, Apr 29, 2024 8:00 AM
Open
0.00
High
0.00
Low
0.00
Close
29.01
Change
0.00%
LDCP
28.01
Volume
0
Total Trades
0
CIRCUIT BREAKER
25.91 — 30.11
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Wed, Jul 6, 2022 3:21 PM
Open
32.52
High
32.99
Low
32.30
Close
32.49
Change
0.99%
LDCP
23.17
Volume
1,708
Total Trades
0
CIRCUIT BREAKER
20.85 — 25.49
DAY RANGE
32.30 — 32.99
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad RiazCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
5,850,891.33
Shares
228,461,200
Free Float
79,961,420
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2024Transmission of Quarterly Report for the period ended View   PDF
Apr 26, 2024Financial Results for the quarter ended View   PDF
Mar 4, 2024Transmission of Quarterly Report for Period Ended View   PDF
Feb 29, 2024Financial Results for the Quarter Ended 2023-12-31 View   PDF
Oct 31, 2023Transmission of Quarterly Report for the Period Ended September 30, 2023 View   PDF
Oct 30, 2023Financial Results for the Quarter Ended September 30, 2023 View   PDF
Oct 6, 2023Transmission of Annual Report for the year ended 30-06-2023 View   PDF
Sep 28, 2023Financial Results for the year ended 30-06-2023 View   PDF
Apr 28, 2023Transmission of Quarterly Report for the Period ended March 31, 2023 View   PDF
Apr 28, 2023Financial Results for the 3rd Quarter ended March 31, 2023 View   PDF
Apr 28, 2023Half Yearly Progress Report for the Period ended December 31, 2022 View   PDF
Apr 28, 2023Annual Progress Report for the Period ended June 30, 2022 View   PDF
DateTitleDocument
Apr 25, 2024Board Meeting in Progress View   
Apr 18, 2024Board Meeting View   
Feb 21, 2024Board Meeting View   
Oct 20, 2023Board Meeting View   
Oct 6, 2023Notice of Annual General Meeting View   PDF
Sep 21, 2023Board Meeting View   
May 29, 2023Results of Board Meeting 26-05-2023 View   PDF
May 26, 2023Emergent Board Meeting in Progress View   
May 25, 2023Board Meeting View   
Apr 20, 2023Board Meeting View   
Feb 27, 2023Board Meeting in Progress View   
DateTitleDocument
Nov 13, 2023Dispatch of Final Dividend Warrants View   PDF
Nov 8, 2023Material Information View   PDF
Sep 21, 2023Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Sep 21, 2023Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 2, 2023Corporate Briefing Session View   PDF
Oct 28, 2022Appointment of Chairman & CEO View   PDF
Oct 28, 2022Change of Management View   PDF
Oct 21, 2022Notice of Election of Directors under section 159(4) of Companies Act, 2017 View   PDF
Feb 22, 2022Material Information View   PDF
Feb 18, 2022Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2023202220212020
Sales12,396,9839,779,8805,795,4043,527,625
Profit after Taxation657,984635,884351,768143,416
EPS2.882.883.6431.87
Q3 2024Q2 2024Q1 2024Q3 2023
Sales3,558,8743,275,1652,701,2282,688,728
Profit after Taxation211,345375,60194,45292,766
EPS0.931.640.410.41
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2023202220212020
Gross Profit Margin (%)12.1613.8313.4712.39
Net Profit Margin (%)5.316.506.074.07
EPS Growth (%)(20.88)(88.58)415.70
PEG(0.54)(0.11)

Payouts

DateFinancial ResultsDetailsBook Closure
September 28, 2023 4:07 PM30/06/2023(YR) 25%(F) (D) 20/10/2023 - 27/10/2023
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports